Market Access & Reimbursement
Securing early access and reimbursement for your products
Veristat Market Access team members provide strategic advice on national early access programs, write HTA/reimbursement dossiers for submission to national HTA bodies and prepare documentation for liaison with private healthcare insurance.
Furthermore, our team supports clients with joint EMA/HTA scientific advice meetings to optimize development plans for successful regulatory and reimbursement approvals.
It's never to early to start. Let's Talk.
Reimbursement Solutions Across the Clinical Development and Commercialization Lifecycle
Market Access Roadmap
- - P&R Strategy
- - Routes to Market Access
- - Early Access Reimbursement
- - Value-based contract solution
Health Technology Assessment (HTA)
- - Dossier strategy
- - Value dossier
- - National HTA dossiers
- - Price review
Pricing
- - Competitor Analysis
- - Pricing Analyses & Strategy
- - Negotiation
- - Price Optimization tactics
Payor Authority Management
- - Payor and HCP Research
- - Objection Handling
- - Advisory Boards
- - KOL liaison